Amyloidosis Center, Boston Medical Center — Boston, Massachusetts

Amyloidosis Center, Boston Medical Center is a clinical research site located in Boston, Massachusetts, United States 02118.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Amyloidosis Center, Boston Medical Center has participated in 2 clinical trials.

Therapeutic areas: Transthyretin Amyloidosis, Amyloidosis, Leptomeningeal, Transthyretin-Related, Familial Amyloid Polyneuropathy.

Sponsors: Boston University.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Amyloidosis Center, Boston Medical Center?

Amyloidosis Center, Boston Medical Center has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Amyloidosis Center, Boston Medical Center conducted?

Amyloidosis Center, Boston Medical Center has 2 clinical trials on record. Their work covers Transthyretin Amyloidosis, Amyloidosis, Leptomeningeal, Transthyretin-Related, Familial Amyloid Polyneuropathy.

Is Amyloidosis Center, Boston Medical Center accredited by Crixeo Health?

Amyloidosis Center, Boston Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Amyloidosis Center, Boston Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.